Browsing by Author "Khalil, Ahmed"
Now showing items 1-4 of 4
-
Assessing Pharmacists Knowledge and Attitude Toward the Direct Oral Anticoagulants in Qatar
El-Bardissy, Ahmed; Elewa, Hazem; Khalil, Ahmed; Mekkawi, Walid; Mohammed, Shaban; Kassem, Mohamed; Alma'moon, Mahmoud Mohamed; Abdelgelil, Mohamed; Eltorki, Yassin; Mohamed, Fadl Abdelfattah A.... more authors ... less authors ( SAGE Publications Inc. , 2020 , Article)Pharmacists were found to play a key role in anticoagulation care. In order to make an appropriate selection and counselling regarding direct oral anticoagulants (DOACs), pharmacists should be knowledgeable and abiding by ... -
Colchicine use might be associated with lower mortality in COVID-19 patients: A meta-analysis
Elshafei, Mohamed Nabil; El-Bardissy, Ahmed; Khalil, Ahmed; Danjuma, Mohammed; Mubasher, Mahmood; Abubeker, Ibrahim Y.; Mohamed, Mouhand F.H.... more authors ... less authors ( Wiley-Blackwell , 2021 , Article)Background: Colchicine was recently repurposed for the management of coronavirus disease 2019 (COVID-19). This rapid review and meta-analysis aimed to assess colchicine's impact on mortality outcomes in COVID-19 patients. ... -
The efficacy of colchicine in the management of coronavirus disease 2019: A protocol for systematic review and meta-analysis
Khalil, Ahmed; El-Bardissy, Ahmed; Danjuma, Mohammed; Ahmed, Mohamed Badie; Mohamed, Mouhand F.H.; Elshafei, M. N.... more authors ... less authors ( Lippincott, Williams & Wilkins , 2020 , Article)BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-COV2) infection is a recently emerged viral infection causing predominantly mild upper respiratory symptoms. However, in some instances, it might result in ... -
Warfarin-Rifampin-Gene (WARIF-G) Interaction: A Retrospective, Genetic, Case–Control Study
Salem, Muhammad; El-Bardissy, Ahmed; Elshafei, Mohamed Nabil; Khalil, Ahmed; Mahmoud, Hesham; Fahmi, Amr Mohamed; Kasem, Mohamed; Bader, Loulia; Sherbash, Mohamed; Elawady, Mostafa Ibrahim; Abdalazim, Walaa; Howady, Faraj; Elewa, Hazem... more authors ... less authors ( Wiley-Blackwell , 2023 , Article)Warfarin is extensively metabolized by cytochrome P450 2C9 (CYP2C9). Concomitant use with the potent CYP2C9 inducer, rifampin, requires close monitoring and dosage adjustments. Although, in theory, warfarin dose increase ...